Literature DB >> 16520556

Secretin induces neurite outgrowth of PC12 through cAMP-mitogen-activated protein kinase pathway.

Hyeon Soo Kim1, Sanatombi Yumkham, Sun-Hee Kim, Kyungmoo Yea, You Chan Shin, Sung Ho Ryu, Pann-Ghill Suh.   

Abstract

The gastrointestinal functions of secretin have been fairly well established. However, its function and mode of action within the nervous system remain largely unclear. To gain insight into this area, we have attempted to determine the effects of secretin on neuronal differentiation. Here, we report that secretin induces the generation of neurite outgrowth in pheochromocytoma PC12 cells. The expressions of Tau and beta-tubulin, neuronal differentiation markers, are increased upon secretin stimulation. In addition, secretin induces sustained mitogen-activated protein kinase (MAPK) activation and also stimulates the cAMP secretion. Moreover, the neurite outgrowth elicited by secretin is suppressed to a marked degree in the presence of either PD98059, a specific MAPK/ERK kinase (MEK) inhibitor, or H89, a specific protein kinase A (PKA) inhibitor. Taken together, these observations demonstrate that secretin induces neurite outgrowth of PC12 cells through cAMP- MAPK pathway, and provide a novel insight into the manner in which secretin participates in neuritogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16520556     DOI: 10.1038/emm.2006.10

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  13 in total

1.  Signaling through the neuropeptide GPCR PAC₁ induces neuritogenesis via a single linear cAMP- and ERK-dependent pathway using a novel cAMP sensor.

Authors:  Andrew C Emery; Lee E Eiden
Journal:  FASEB J       Date:  2012-04-24       Impact factor: 5.191

2.  The knockout of secretin in cerebellar Purkinje cells impairs mouse motor coordination and motor learning.

Authors:  Li Zhang; Sookja Kim Chung; Billy Kwok Chong Chow
Journal:  Neuropsychopharmacology       Date:  2013-12-19       Impact factor: 7.853

3.  Progesterone regulates secretin expression in mouse uterus during early pregnancy.

Authors:  Zhu Huang; Tong-Song Wang; Qian-Rong Qi; Ru-Juan Zuo; Xiao-Huan Liang; Xu-Yu Zhao; Zeng-Ming Yang
Journal:  Reprod Sci       Date:  2013-12-13       Impact factor: 3.060

4.  Secretin mRNA in the subdivision of primary sensory neurons in the trigeminal ganglion of rats.

Authors:  Andrea Heinzlmann; Zsuzsanna E Tóth; Katalin Köves
Journal:  J Mol Neurosci       Date:  2010-06-26       Impact factor: 3.444

5.  Cyclic AMP-dependent protein kinase A and EPAC mediate VIP and secretin stimulation of PAK4 and activation of Na+,K+-ATPase in pancreatic acinar cells.

Authors:  Irene Ramos-Alvarez; Lingaku Lee; R T Jensen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-12-06       Impact factor: 4.052

6.  Heparin-binding epidermal growth factor-like growth factor is a potent neurotrophic factor for PC12 cells.

Authors:  Yu Zhou; Gail E Besner
Journal:  Neurosignals       Date:  2010-09-16

7.  Secretin attenuates the hereditary repetitive hyperactive movements in a mouse model.

Authors:  Katalin Köves; Gusztav Kiss; Andrea Heinzlmann; Roberta Dochnal; M Manczinger; Agnes Pál; I Sípos; Gyula Szabó
Journal:  J Mol Neurosci       Date:  2010-07-06       Impact factor: 3.444

8.  Secretin receptor promotes the proliferation of endocrine tumor cells via the PI3K/AKT pathway.

Authors:  Misu Lee; Beatrice Waser; Jean-Claude Reubi; Natalia S Pellegata
Journal:  Mol Endocrinol       Date:  2012-06-12

9.  Regulatory effect of nerve growth factor on release of substance P in cultured dorsal root ganglion neurons of rat.

Authors:  Xiang-Dong Yang; Zhen Liu; Hua-Xiang Liu; Li-Hong Wang; Chun-Hong Ma; Zhen-Zhong Li
Journal:  Neurosci Bull       Date:  2007-07       Impact factor: 5.203

10.  AMP N(1)-oxide, a unique compound of royal jelly, induces neurite outgrowth from PC12 cells via signaling by protein kinase A independent of that by mitogen-activated protein kinase.

Authors:  Noriko Hattori; Hiroshi Nomoto; Hidefumi Fukumitsu; Satoshi Mishima; Shoei Furukawa
Journal:  Evid Based Complement Alternat Med       Date:  2007-10-29       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.